Market Research Logo

Belarus Pharmaceuticals and Healthcare Report Q2 2016

Belarus Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Government initiatives to boost the nascent domestic pharmaceutical industry and reduce thereliance on imports will limit the attractiveness of Belarus to multinational drugmakers. Governmentinterference, in the form of domestic bias in the medicine tendering process and pricing controls, willfurther reduce revenue earning opportunities. Additional risks include a continued poor economic forecastand rising regional geopolitical tensions.

Headline Expenditure Projections

Pharmaceuticals: BYR12,247bn in 2015 (USD801mn) to BYR14,219bn (USD783mn) in 2016; +16.1% inlocal currency terms and -2.1% in US dollar terms.

Healthcare: BYR60,885bn (USD3.98bn) in 2015 to BYR71,906bn (USD3.96bn) in 2016; +18.1% in localcurrency terms and -0.4% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Belarus 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2014-2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index
Belarus Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Belarus 2010-2015)
Table: Healthcare Personnel (Belarus 2010-2015)
Table: Healthcare Activity (Belarus 2010-2015)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Lekpharm
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Belarus 1990-2025)
Table: Key Population Ratios (Belarus 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Belarus 1990-2025)
Table: Population By Age Group (Belarus 1990-2025)
Table: Population By Age Group % (Belarus 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report